Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Autism Res Treat ; 2013: 609705, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24224089

RESUMEN

Treatments targeting metabolic abnormalities in children with autism are limited. Previously we reported that a nutritional treatment significantly improved glutathione metabolism in children with autistic disorder. In this study we evaluated changes in adaptive behaviors in this cohort and determined whether such changes are related to changes in glutathione metabolism. Thirty-seven children diagnosed with autistic disorder and abnormal glutathione and methylation metabolism were treated with twice weekly 75 µg/Kg methylcobalamin and twice daily 400 µg folinic acid for 3 months in an open-label fashion. The Vineland Adaptive Behavior Scale (VABS) and glutathione redox metabolites were measured at baseline and at the end of the treatment period. Over the treatment period, all VABS subscales significantly improved with an average effect size of 0.59, and an average improvement in skills of 7.7 months. A greater improvement in glutathione redox status was associated with a greater improvement in expressive communication, personal and domestic daily living skills, and interpersonal, play-leisure, and coping social skills. Age, gender, and history of regression did not influence treatment response. The significant behavioral improvements observed and the relationship between these improvements to glutathione redox status suggest that nutritional interventions targeting redox metabolism may benefit some children with autism.

2.
Am J Clin Nutr ; 89(1): 425-30, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19056591

RESUMEN

BACKGROUND: Metabolic abnormalities and targeted treatment trials have been reported for several neurobehavioral disorders but are relatively understudied in autism. OBJECTIVE: The objective of this study was to determine whether or not treatment with the metabolic precursors, methylcobalamin and folinic acid, would improve plasma concentrations of transmethylation/transsulfuration metabolites and glutathione redox status in autistic children. DESIGN: In an open-label trial, 40 autistic children were treated with 75 microg/kg methylcobalamin (2 times/wk) and 400 microg folinic acid (2 times/d) for 3 mo. Metabolites in the transmethylation/transsulfuration pathway were measured before and after treatment and compared with values measured in age-matched control children. RESULTS: The results indicated that pretreatment metabolite concentrations in autistic children were significantly different from values in the control children. The 3-mo intervention resulted in significant increases in cysteine, cysteinylglycine, and glutathione concentrations (P < 0.001). The oxidized disulfide form of glutathione was decreased and the glutathione redox ratio increased after treatment (P < 0.008). Although mean metabolite concentrations were improved significantly after intervention, they remained below those in unaffected control children. CONCLUSION: The significant improvements observed in transmethylation metabolites and glutathione redox status after treatment suggest that targeted nutritional intervention with methylcobalamin and folinic acid may be of clinical benefit in some children who have autism. This trial was registered at (clinicaltrials.gov) as NCT00692315.


Asunto(s)
Trastorno Autístico/metabolismo , Glutatión/metabolismo , Leucovorina/farmacología , Estado Nutricional , Vitamina B 12/análogos & derivados , Complejo Vitamínico B/farmacología , Trastorno Autístico/sangre , Niño , Preescolar , Cromatografía Líquida de Alta Presión , Suplementos Dietéticos , Femenino , Glutatión/sangre , Humanos , Leucovorina/sangre , Masculino , Metilación , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , S-Adenosilhomocisteína/sangre , S-Adenosilhomocisteína/metabolismo , S-Adenosilmetionina/sangre , S-Adenosilmetionina/metabolismo , Resultado del Tratamiento , Vitamina B 12/sangre , Vitamina B 12/farmacología , Complejo Vitamínico B/sangre
4.
J Autism Dev Disord ; 38(10): 1966-75, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18512136

RESUMEN

An integrated metabolic profile reflects the combined influence of genetic, epigenetic, and environmental factors that affect the candidate pathway of interest. Recent evidence suggests that some autistic children may have reduced detoxification capacity and may be under chronic oxidative stress. Based on reports of abnormal methionine and glutathione metabolism in autistic children, it was of interest to examine the same metabolic profile in the parents. The results indicated that parents share similar metabolic deficits in methylation capacity and glutathione-dependent antioxidant/detoxification capacity observed in many autistic children. Studies are underway to determine whether the abnormal profile in parents reflects linked genetic polymorphisms in these pathways or whether it simply reflects the chronic stress of coping with an autistic child.


Asunto(s)
Trastorno Autístico/epidemiología , ADN/metabolismo , Metilación , Padres , Niño , Humanos
5.
Telemed J E Health ; 12(1): 35-41, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16478411

RESUMEN

The purpose was to examine the organizational impact of a state-wide high-risk pregnancy telemedical system, Antenatal and Neonatal Guidelines, Education and Learning System (ANGELS), after the first year of its roll out. The focus is on several aspects of system organization, including the volume and diversity of patient-based telemedical consultations and weekly telemedical case discussions, telephone consultations, and changes in the pattern of birth-related patient transports. Individual data on patient transports and associated hospital days, provider-specialist telephone calls, and telemedical consultations were collected for two time periods: December 2002-May 2003 (prior to initiation of ANGELS), and December 2003-May 2004 (postinitiation of ANGELS). Different statistical tests were constructed to compare the two periods as appropriate. Significant increases were observed in the volume and geographic diversity of telemedical consultations and the volume of telephone consultations. There was a moderate, but nonsignificant decrease in the number of maternal transports to University of Arkansas School of Medical Sciences (UAMS), and the average length of stay decreased. The type of specialist-provider and specialist-patient contact has changed as the ANGELS high-risk pregnancy telemedical system has evolved over the first year. We conclude that the rollout of the ANGELS program is changing the shape of high-risk patient care in Arkansas, and we attribute that to an evolving collegial network between specialists and generalists.


Asunto(s)
Embarazo de Alto Riesgo , Telemedicina/organización & administración , Femenino , Hospitales Universitarios , Humanos , Tiempo de Internación , Embarazo , Transporte de Pacientes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA